Replimune Group Inc buy Barclays PLC
Start price
06.12.23
/
50%
€6.90
Target price
06.12.24
€12.05
Performance (%)
-6.52%
Price
06.05.24
€6.35
Summary
This prediction is currently active. With a performance of -6.52%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 06.12.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | 4.959% | 4.959% |
| iShares Core DAX® | 2.831% | 1.236% |
| iShares Nasdaq 100 | 2.918% | 0.640% |
| iShares Nikkei 225® | 2.007% | -2.135% |
| iShares S&P 500 | 2.257% | 0.451% |
Comments by Barclays_PLC for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) had its price target lowered by analysts at Barclays PLC from $50.00 to $13.00. They now have an "overweight" rating on the stock.
Ratings data for REPL provided by MarketBeat